Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Melck

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Current Medicinal Chemistry|September 2, 1999
Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoidsV Di Marzo, T Bisogno, L De Petrocellis, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Beta-casomorphins: substitution of phenylalanine with beta-homo phenylalanine increases the mu-type opioid receptor affinityL Longobardo, D Melck, R Siciliano, et al.
The Biochemical Journal|March 1, 1997
Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cellsT Bisogno, N Sepe, D Melck, et al.
FEBS Letters|December 22, 1999
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cellsD Melck, D Rueda, I Galve-Roperh, et al.
Endocrinology|December 30, 1999
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferationD Melck, L De Petrocellis, P Orlando, et al.
Biochemical and Biophysical Research Communications|August 17, 1999
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptorsD Melck, T Bisogno, L De Petrocellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferationL De Petrocellis, D Melck, A Palmisano, et al.
European Journal of Biochemistry|August 4, 1998
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiationT Bisogno, K Katayama, D Melck, et al.
European Journal of Biochemistry|August 14, 1999
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophagesV Di Marzo, T Bisogno, L De Petrocellis, et al.
The European Respiratory Journal|July 26, 2008
Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopyG de Laurentiis, D Paris, D Melck, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Current Medicinal Chemistry|September 2, 1999
Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoidsV Di Marzo, T Bisogno, L De Petrocellis, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Beta-casomorphins: substitution of phenylalanine with beta-homo phenylalanine increases the mu-type opioid receptor affinityL Longobardo, D Melck, R Siciliano, et al.
The Biochemical Journal|March 1, 1997
Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cellsT Bisogno, N Sepe, D Melck, et al.
FEBS Letters|December 22, 1999
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cellsD Melck, D Rueda, I Galve-Roperh, et al.
Endocrinology|December 30, 1999
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferationD Melck, L De Petrocellis, P Orlando, et al.
Biochemical and Biophysical Research Communications|August 17, 1999
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptorsD Melck, T Bisogno, L De Petrocellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferationL De Petrocellis, D Melck, A Palmisano, et al.
European Journal of Biochemistry|August 4, 1998
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiationT Bisogno, K Katayama, D Melck, et al.
European Journal of Biochemistry|August 14, 1999
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophagesV Di Marzo, T Bisogno, L De Petrocellis, et al.
The European Respiratory Journal|July 26, 2008
Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopyG de Laurentiis, D Paris, D Melck, et al.
Pageof 3